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Background 
 Totaling more than 2.1 million treatments in 2015, dermal filler treatments of 
hyaluronic acids (HAs) are the second most common in-office cosmetic procedure 
performed in the United States (van Loghem, Humzah, & Kerscher, 2016). In an attempt 
to minimize dermal filler complications, blunt-tipped cannulas have emerged as an 
alternative technique to the use of 27-gauge needle administration. Because blunt-tipped 
cannulas navigate through the dermis without the sharp tip of a needle, cannulas are 
believed to cause less pain and bruising in addition to less risk of arterial embolization 
(AE) (Ozturk et al., 2013).  
Intra-procedural pain and extended post procedure recovery due to bruising are 
dermal filler complications that negatively impact patient overall experience (Brandt, 
Bank, Cross, & Weiss, 2010). Therefore, techniques to limit these complications are 
important in a competitive consumer based medical model such as that seen in a med-spa. 
The ability to offer potential clients a less painful technique, with less bruising and less 
risk of arterial embolization is a significant competitive advantage. A Southern California 
medical practice with three facilities and five aesthetic providers was selected as the site 
for an evidence based project to evaluate a best practice technique.   
Introduction to the Evidence 
A review of the literature was conducted via electronic searches through an 
institution library. Databases searched included PubMed, Cochrane and CINAHL. 
Articles were synthesized and evaluated based on relevancy, applicability to practice 
setting, level of evidence and publication date.  When utilizing similar aesthetic 
technique, both cannula and needle have been shown to provide equal aesthetic 
improvement with less pain and bruising as compared to needle administration (Fulton, 
Caperton, Weinkle & Dewandre, 2012). A study of cadaver heads evaluating placement 
of HAs by both cannula and needle demonstrated a more precise placement with cannula 
use and intra-arterial injection with needle (van Loghem, Humzah, & Kerscher 2016). 
Although no specific clinical trials or studies have demonstrated cannula use completely 
prevents AE, cannula use is recommended to decrease AE events (Yeh, Fabi, & Welsh, 
2017). Additional techniques shown to decrease pain, bruising and AE include aspiration 
before injection, retrograde injection, slow speed of injection, and reduced ejection force 
(Glogau & Kane, 2008). However, it is important to note that Yeh, Fabi and Welsh 
(2017), reported two cases of AE occurred while using a blunt-tipped cannula. 
In a 2012 article by Lazzeri et al., serious complications arising from AE were 
explored. Of the 32 cases reviewed, 29 documented cases of blindness followed dermal 
filler administration were attributed to AE. Complication rates of AE from dermal fillers 
are unclear, but a 2011 estimate reported a 0.0001% risk of AE with the glabella, nose 
and nasal labial folds as the areas most frequently affected (Ozturk et al., 2013). 
Although dermal filler administration is a relatively low risk procedure, research 
highlights that provider technique and knowledge of anatomy are important factors in 
decreasing the risk of AE (van Loghem, Humzah & Kerscher, 2016). 
Methods 
Comparing intra-procedural pain and post-procedural bruising in patients 
receiving dermal filler administration for mid and lower face volumization was 
established as the project purposed. A six-week time period was identified and 24 female 
patients presenting for volumization of the mid and lower face were enrolled in the 
project. Patient demographics to include age, number of previous dermal filler treatments 
and history of aspirin product within 48 hours of the treatment was collected (see Table 
1).  







The face was divided into four treatment quadrants with all treatments being 
initiated in the right upper quadrant. Subsequent treatments followed a clockwise pattern 
until the right lower quadrant was reached (see figure 1).  
 
Figure 1. Four Facial Quadrants 
 
Table: 1 Age Range 
(years) 
Total (n) 
 21-35 3 
 36-50 11 
 51-65 10 
Average Age (years) 47  
Aspirin taken within 48 
hours (n) 
0  
Average number of 
previous HA treatments 
1.29  
Patients were administered a total of two milliliters (ml) of hyaluronic acid, one 
ml per side for treatment of the mid and lower face. Each patient had one side of their 
face randomized and treated with a 27-gauge, 1-inch blunt-tip cannula and the other side 
treated via the pre-packaged 27-gauge 1-inch needle. 1 milliliter of hyaluronic acid was 
administered to each side and the same injector performed all treatments after pretreating 
the area with a topical anesthetic.  
Upon the completion of treatment for each quadrant, participants were asked to 
rate their pain on a Likert-type scale that ranges from 0 to 10. Participants were instructed 
that a rating of 10 equals intense pain and a rating of 0 equals no pain. All patients 
received discharge instructions not to massage the area and to return in 2 days. Upon 
return to the clinic, patients were interviewed regarding their adherence to the discharge 
instructions given to them at the previous visit. If bruising was assessed, bruising for each 
quadrant was recorded in millimeters.  
  
Results 
The average diameter for bruising with cannula administration was 0.43 mm in 
comparison to 1.68 mm with needle administration and was statistically significant (p < 
0.01) (see figure 2). When bruising present, bruising with cannula use was less in all four 
quadrants in comparison to needle. 
 
Figure 2. Overall Bruising Comparison between Needle and Cannula  
 Pain was also less in cannula administration with overall pain rated as 1.93 as 
compared to 3.18 with needle administration (p < 0.01) (see figure 3). In support of the 
evidence, cannula use also resulted in less pain in all four quadrants in comparison to 
pain. 
 Figure 3. Overall Pain on Likert Scale from 0 to 10 
Cannula use not only resulted in overall less pain and bruising, when bruising was 
present, bruising from needles averaged 3.12 mm as compared to only 2.5 mm with 
cannula. Additionally, bruising was not present in 83% of areas treated with cannula in 
comparison to only 45% for areas treated with a needle. 
Costs Savings 
 The total additional cost associated with the EBP implementation was $150.00. 
EBP costs consisted of $6.00 per cannula and one 30-minute training session for five 
non-medical staff. Other than the additional material cost of purchasing one $6.00 
cannula per patient, inclusion of cannulas does not have cause the practice to incur any 
additional fixed costs. However, in order to provide more information on the advantages 
of cannula technique to the clinics market base, additional marketing tools to include 
website modification, magazines, email campaigns, and in-clinic advertising flyers will 
need to be considered.  
In contrast to the relatively low product cost, cannula use has significant potential 
for business growth. EBP findings support decreased pain and hematoma formation when 
using cannula. As a result, patients receiving dermal fillers via cannula technique would 
be more likely to have an improved overall experience from those who received dermal 
fillers via needle. Considering that aesthetic medicine is a consumer-based practice 
model, the blunt-tipped cannula technique would help increase practice revenue due to 
improved patient experience 
Implications for Practice 
An important secondary gain of blunt-tipped use would be the potential decrease 
in arterial embolization (Hexsel et al., 2012). Van Loghem, Humzah, and Kerscher 
(2016) suggest that the smooth tip of the cannula may protect patients against inadvertent 
injection of hyaluronic acid within the artery. Because the smooth tip of the cannula 
cannot puncture the vessel wall, the cannula navigates through the dermis, pushing soft 
tissue structures such as blood vessels out of the way. Although the authors admit that the 
risk of embolization still occurs, it is suggested that the risk is significantly less with 
cannula use. Additional research in arterial embolization from cosmetic procedures is 
needed to fully understand the risk that patients take with dermal fillers. 
Sustainability 
Sustainability of the project will be challenged by tendencies for providers to 
resort back to familiar injection techniques utilizing a needle. Additional challenges are 
expected due to the material costs of purchasing cannulas. However, after considering the 
decreased risk of AE and increased business growth, sustainability should be a priority 
for both the clinician and the organization as a whole.  
A decrease risk in hematoma formation and potential embolization of facial 
arteries provide a safer environment for the aesthetic provider to practice and this idea 
will need to be reinforced by the lead DNP for the practice.  It is expected that patient’s 
preference for treatments that result in decreased pain and bruising will also help 
sustainability. Ultimately, the facility will be responsible for practice guidelines updates 
and enforcement.  
Limitations 
Sample size for the EBP was relatively small. It is recommended that a longer 
time frame, or period of time with higher volume be considered for future projects. 
Additional limitations to the project included a lack of male patients, and few patients 
with no history of previous dermal fillers. Research into cool packs and their affect on 
bruising was not established as well as a bruising tool with established reliability and 
validity was not utilized. However, a literature review failed to locate a standardized 
bruising tool for the assessment of bruising post cosmetic facial procedure. 
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